SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235 | +147.4% | 67,754 | +229.1% | 0.02% | +122.2% |
| Q1 2023 | $95 | -73.3% | 20,588 | -53.2% | 0.01% | -79.5% |
| Q4 2022 | $356 | -100.0% | 44,032 | -73.4% | 0.04% | -63.9% |
| Q3 2022 | $919,000 | -19.1% | 165,544 | -24.1% | 0.12% | -28.2% |
| Q2 2022 | $1,136,000 | +290.4% | 218,115 | +515.4% | 0.17% | +335.9% |
| Q1 2022 | $291,000 | -72.6% | 35,442 | -50.4% | 0.04% | -70.9% |
| Q4 2021 | $1,063,000 | – | 71,412 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |